Influence of estrogens and antiestrogens on the expression of selected hormone-responsive genes

Piero Sismondi, Nicoletta Biglia, Riccardo Ponzone, Luca Fuso, Claudio Scafoglio, Luigi Cicatiello, Maria Ravo, Alessandro Weisz, Daniela Cimino, Gioia Altobelli, Olivier Friard, Michele De Bortoli

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Estrogen exerts a primary regulatory role on a wide variety of physiological processes in different tissues and organs. Agonistic ad antagonistic compounds are widely used in human health and, therefore, a deep understanding of their mechanisms of action at the molecular level is mandatory. The effect of 17β-estradiol and three antiestrogenic drugs, comprising two selective estrogen receptor modulator (SERM, 4-OH-tamoxifen, Raloxifene) and the pure antiestrogen ICI 182,780, on genome-wide gene expression levels was evaluated in breast carcinoma cell lines by DNA microarray analysis. Different clusters of genes, showing specific coregulation patterns, were found. First, several groups of genes displaying temporal-specific up- or down-regulation were characterized. Second, clusters of genes responding to different antiestrogenic drugs in either antagonstic or agonistic fashion, were found. Genes responding specifically to antiestrogens, but not to estrogen, were also identified. In addition, each individual compound exhibited a very specific gene regulation. Bioinformatic analysis was applied to the regulatory sequences of different groups of genes and confirmed that specific pathways and secondary responses are activated at each temporal point and in response to different compounds. Our results underline the complexity of genomic responses to estrogen in breast cancer cells and strongly suggest that the molecular characterization of estrogen agonists and antagonists used in human therapy should be carefully studied.

Original languageEnglish
Pages (from-to)50-55
Number of pages6
JournalMaturitas
Volume57
Issue number1
DOIs
Publication statusPublished - May 20 2007

Fingerprint

Estrogen Receptor Modulators
Estrogens
Genes
Hormones
Selective Estrogen Receptor Modulators
Multigene Family
Breast Neoplasms
Physiological Phenomena
Estrogen Antagonists
Gene expression
Tamoxifen
Microarray Analysis
Oligonucleotide Array Sequence Analysis
Computational Biology
Cells
Pharmaceutical Preparations
Estradiol
Up-Regulation
Down-Regulation
Genome

Keywords

  • Antagonists
  • Estrogen
  • Human therapy

ASJC Scopus subject areas

  • Ageing
  • Obstetrics and Gynaecology

Cite this

Sismondi, P., Biglia, N., Ponzone, R., Fuso, L., Scafoglio, C., Cicatiello, L., ... De Bortoli, M. (2007). Influence of estrogens and antiestrogens on the expression of selected hormone-responsive genes. Maturitas, 57(1), 50-55. https://doi.org/10.1016/j.maturitas.2007.02.019

Influence of estrogens and antiestrogens on the expression of selected hormone-responsive genes. / Sismondi, Piero; Biglia, Nicoletta; Ponzone, Riccardo; Fuso, Luca; Scafoglio, Claudio; Cicatiello, Luigi; Ravo, Maria; Weisz, Alessandro; Cimino, Daniela; Altobelli, Gioia; Friard, Olivier; De Bortoli, Michele.

In: Maturitas, Vol. 57, No. 1, 20.05.2007, p. 50-55.

Research output: Contribution to journalArticle

Sismondi, P, Biglia, N, Ponzone, R, Fuso, L, Scafoglio, C, Cicatiello, L, Ravo, M, Weisz, A, Cimino, D, Altobelli, G, Friard, O & De Bortoli, M 2007, 'Influence of estrogens and antiestrogens on the expression of selected hormone-responsive genes', Maturitas, vol. 57, no. 1, pp. 50-55. https://doi.org/10.1016/j.maturitas.2007.02.019
Sismondi, Piero ; Biglia, Nicoletta ; Ponzone, Riccardo ; Fuso, Luca ; Scafoglio, Claudio ; Cicatiello, Luigi ; Ravo, Maria ; Weisz, Alessandro ; Cimino, Daniela ; Altobelli, Gioia ; Friard, Olivier ; De Bortoli, Michele. / Influence of estrogens and antiestrogens on the expression of selected hormone-responsive genes. In: Maturitas. 2007 ; Vol. 57, No. 1. pp. 50-55.
@article{bb4602558fe84ea49a4c6b0ee2854d58,
title = "Influence of estrogens and antiestrogens on the expression of selected hormone-responsive genes",
abstract = "Estrogen exerts a primary regulatory role on a wide variety of physiological processes in different tissues and organs. Agonistic ad antagonistic compounds are widely used in human health and, therefore, a deep understanding of their mechanisms of action at the molecular level is mandatory. The effect of 17β-estradiol and three antiestrogenic drugs, comprising two selective estrogen receptor modulator (SERM, 4-OH-tamoxifen, Raloxifene) and the pure antiestrogen ICI 182,780, on genome-wide gene expression levels was evaluated in breast carcinoma cell lines by DNA microarray analysis. Different clusters of genes, showing specific coregulation patterns, were found. First, several groups of genes displaying temporal-specific up- or down-regulation were characterized. Second, clusters of genes responding to different antiestrogenic drugs in either antagonstic or agonistic fashion, were found. Genes responding specifically to antiestrogens, but not to estrogen, were also identified. In addition, each individual compound exhibited a very specific gene regulation. Bioinformatic analysis was applied to the regulatory sequences of different groups of genes and confirmed that specific pathways and secondary responses are activated at each temporal point and in response to different compounds. Our results underline the complexity of genomic responses to estrogen in breast cancer cells and strongly suggest that the molecular characterization of estrogen agonists and antagonists used in human therapy should be carefully studied.",
keywords = "Antagonists, Estrogen, Human therapy",
author = "Piero Sismondi and Nicoletta Biglia and Riccardo Ponzone and Luca Fuso and Claudio Scafoglio and Luigi Cicatiello and Maria Ravo and Alessandro Weisz and Daniela Cimino and Gioia Altobelli and Olivier Friard and {De Bortoli}, Michele",
year = "2007",
month = "5",
day = "20",
doi = "10.1016/j.maturitas.2007.02.019",
language = "English",
volume = "57",
pages = "50--55",
journal = "Maturitas",
issn = "0378-5122",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Influence of estrogens and antiestrogens on the expression of selected hormone-responsive genes

AU - Sismondi, Piero

AU - Biglia, Nicoletta

AU - Ponzone, Riccardo

AU - Fuso, Luca

AU - Scafoglio, Claudio

AU - Cicatiello, Luigi

AU - Ravo, Maria

AU - Weisz, Alessandro

AU - Cimino, Daniela

AU - Altobelli, Gioia

AU - Friard, Olivier

AU - De Bortoli, Michele

PY - 2007/5/20

Y1 - 2007/5/20

N2 - Estrogen exerts a primary regulatory role on a wide variety of physiological processes in different tissues and organs. Agonistic ad antagonistic compounds are widely used in human health and, therefore, a deep understanding of their mechanisms of action at the molecular level is mandatory. The effect of 17β-estradiol and three antiestrogenic drugs, comprising two selective estrogen receptor modulator (SERM, 4-OH-tamoxifen, Raloxifene) and the pure antiestrogen ICI 182,780, on genome-wide gene expression levels was evaluated in breast carcinoma cell lines by DNA microarray analysis. Different clusters of genes, showing specific coregulation patterns, were found. First, several groups of genes displaying temporal-specific up- or down-regulation were characterized. Second, clusters of genes responding to different antiestrogenic drugs in either antagonstic or agonistic fashion, were found. Genes responding specifically to antiestrogens, but not to estrogen, were also identified. In addition, each individual compound exhibited a very specific gene regulation. Bioinformatic analysis was applied to the regulatory sequences of different groups of genes and confirmed that specific pathways and secondary responses are activated at each temporal point and in response to different compounds. Our results underline the complexity of genomic responses to estrogen in breast cancer cells and strongly suggest that the molecular characterization of estrogen agonists and antagonists used in human therapy should be carefully studied.

AB - Estrogen exerts a primary regulatory role on a wide variety of physiological processes in different tissues and organs. Agonistic ad antagonistic compounds are widely used in human health and, therefore, a deep understanding of their mechanisms of action at the molecular level is mandatory. The effect of 17β-estradiol and three antiestrogenic drugs, comprising two selective estrogen receptor modulator (SERM, 4-OH-tamoxifen, Raloxifene) and the pure antiestrogen ICI 182,780, on genome-wide gene expression levels was evaluated in breast carcinoma cell lines by DNA microarray analysis. Different clusters of genes, showing specific coregulation patterns, were found. First, several groups of genes displaying temporal-specific up- or down-regulation were characterized. Second, clusters of genes responding to different antiestrogenic drugs in either antagonstic or agonistic fashion, were found. Genes responding specifically to antiestrogens, but not to estrogen, were also identified. In addition, each individual compound exhibited a very specific gene regulation. Bioinformatic analysis was applied to the regulatory sequences of different groups of genes and confirmed that specific pathways and secondary responses are activated at each temporal point and in response to different compounds. Our results underline the complexity of genomic responses to estrogen in breast cancer cells and strongly suggest that the molecular characterization of estrogen agonists and antagonists used in human therapy should be carefully studied.

KW - Antagonists

KW - Estrogen

KW - Human therapy

UR - http://www.scopus.com/inward/record.url?scp=34247115465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247115465&partnerID=8YFLogxK

U2 - 10.1016/j.maturitas.2007.02.019

DO - 10.1016/j.maturitas.2007.02.019

M3 - Article

VL - 57

SP - 50

EP - 55

JO - Maturitas

JF - Maturitas

SN - 0378-5122

IS - 1

ER -